Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get trading ideas, historical data, advanced options screeners, more. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Lexaria Bioscience Corp (LEXX)
Lexaria Bioscience Corp (LEXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,690
  • Shares Outstanding, K 5,986
  • Annual Sales, $ 260 K
  • Annual Income, $ -7,270 K
  • 60-Month Beta 0.59
  • Price/Sales 17.61
  • Price/Cash Flow N/A
  • Price/Book 0.97
Trade LEXX with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.17
  • Most Recent Earnings -0.22 on 04/14/23
  • Next Earnings Date 07/13/23
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.6500 +20.55%
on 05/22/23
2.2900 -65.78%
on 04/27/23
-1.4764 (-65.33%)
since 04/26/23
3-Month
0.6500 +20.55%
on 05/22/23
3.5953 -78.20%
on 03/06/23
-2.2164 (-73.88%)
since 02/24/23
52-Week
0.6500 +20.55%
on 05/22/23
3.6000 -78.23%
on 08/15/22
-1.2264 (-61.01%)
since 05/26/22

Most Recent Stories

More News
Lexaria Bioscience (NASDAQ: LEXX) Announces Positive Findings from DehydraTECH-CBD Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced additional findings from last year’s human clinical study HYPER-H21-4. The findings demonstrate...

LEXX : 0.7836 (+4.48%)
LEXXW : 0.1500 (+17.10%)
Lexaria Bioscience (NASDAQ: LEXX) Announces Pivotal Milestones Concerning DehydraTECH(TM)

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, is improving how active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting healthier oral ingestion...

LEXX : 0.7836 (+4.48%)
Lexaria Bioscience (NASDAQ: LEXX) Kicks Off FDA IND Filing Process with Granted CRO Contract

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just announced the awarding of the contract for clinical research organization (“CRO”) services to California-based...

LEXX : 0.7836 (+4.48%)
Lexaria Bioscience (NASDAQ: LEXX) Secures $2M in Public Offering

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, has announced the closing of its public offering of 2,106,000 units, with each consisting of one share of common...

LEXX : 0.7836 (+4.48%)
LEXXW : 0.1500 (+17.10%)
Lexaria Bioscience (NASDAQ: LEXX) Announces Results of 2023 Annual Meeting

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced the results of the 2023 Annual Meeting. According to the update, the company held the meeting at...

LEXXW : 0.1500 (+17.10%)
LEXX : 0.7836 (+4.48%)
Lexaria Bioscience (NASDAQ: LEXX) Announces Dosing Completed on Human Nicotine Study

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has completed dosing for 36 subjects in its human clinical oral nicotine study: NIC-H22-1. According to the announcement,...

LEXX : 0.7836 (+4.48%)
Lexaria Bioscience (NASDAQ: LEXX) Announces Four New Patents Added to Portfolio

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms and the global leader in enhancing the speed and efficiency of orally-delivered fat-soluble active molecules and drugs through...

LEXX : 0.7836 (+4.48%)
Lexaria’s (NASDAQ: LEXX) Successful Study Indicates One of Potential Applications for DehydraTECH(TM)

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms. The company’s patented DehydraTECH(TM) drug delivery platform technology increases bioavailability, improving the way...

LEXX : 0.7836 (+4.48%)
Lexaria Bioscience (NASDAQ: LEXX) Expanding Portfolio with Four New Patents

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that it has received notifications of four new patents either awarded or allowed. In Japan, the...

LEXX : 0.7836 (+4.48%)
LEXXW : 0.1500 (+17.10%)
Lexaria (NASDAQ: LEXX) Eyes Licensed Use of DehydraTECH(TM) to Complement Royalty Earnings

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, has, since its inception, stayed committed to creating shareholder value and exploring different avenues for growth. This...

LEXX : 0.7836 (+4.48%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Lexaria Bioscience Corp. provides drug delivery platforms. Its patented DehydraTECH(TM) drug delivery technology changes the way Active Pharmaceutical Ingredients enter the bloodstream, promoting healthier ingestion methods, lower overall dosing and higher effectiveness for lipophilic active molecules....

See More

Key Turning Points

3rd Resistance Point 0.9224
2nd Resistance Point 0.8812
1st Resistance Point 0.8324
Last Price 0.7836
1st Support Level 0.7424
2nd Support Level 0.7012
3rd Support Level 0.6524

See More

52-Week High 3.6000
Fibonacci 61.8% 2.4731
Fibonacci 50% 2.1250
Fibonacci 38.2% 1.7769
Last Price 0.7836
52-Week Low 0.6500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar